GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » SPO Global Inc (OTCPK:SPOM) » Definitions » Beta

SPO Global (SPO Global) Beta : 0.11 (As of May. 24, 2024)


View and export this data going back to . Start your Free Trial

What is SPO Global Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-05-24), SPO Global's Beta is 0.11.


SPO Global Beta Historical Data

The historical data trend for SPO Global's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SPO Global Beta Chart

SPO Global Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.69 -1.67 -1.26 -2.89 -1.29

SPO Global Quarterly Data
Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep22 Sep23
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.29 -0.28 -0.06 -8.09 -0.16

Competitive Comparison of SPO Global's Beta

For the Conglomerates subindustry, SPO Global's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SPO Global's Beta Distribution in the Conglomerates Industry

For the Conglomerates industry and Industrials sector, SPO Global's Beta distribution charts can be found below:

* The bar in red indicates where SPO Global's Beta falls into.



SPO Global Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


SPO Global  (OTCPK:SPOM) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


SPO Global Beta Related Terms

Thank you for viewing the detailed overview of SPO Global's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


SPO Global (SPO Global) Business Description

Traded in Other Exchanges
N/A
Address
Jinan Pharma Valley, 27th Floor Block A J, Shandong, CHN, 33634
SPO Global Inc is a holding company whose strategic plan is to acquire interests in emerging young businesses and provide financing, advice and guidance to assist them in realizing their potential. The Company is implementing an acquisition roll-up model of acquiring sales, marketing, and manufacturing businesses. The business scope of the company includes bio-pharmaceutical Research and development, development and sales of medical informatization software, medical high-tech introduction, production and sales of medical quality supplies, dietary supplements, and medicine, as well as agents and sales of medical equipment supplies.
Executives
Jeffrey Louis Feuer officer: Chief Financial Officer 21860 BURBANK BLVD SUITE 380, WOODLAND HILLS CA 91367
Richard H Ryan officer: Chief Operating Officer 21860 BURBANK BLVD., NORTH BUILDING SUITE 380, WOODLAND HILLS CA 91367
Michael Braunold director, officer: Chief Executive Officer C/O AUBIENT CORP, 1033 BECON ST, BROOKLINE MA 02446
Sidney Braun director SUITE 404, 6711 MISSISSAUGA ROAD, MISSISSAUGA A6 L5N 2W3
Pauline Dorfman director 183 REINER ROAD, TORONTO A6 M3H 2L8
Israel Sarussi 10 percent owner, officer: Chief Technology Officer C/O SPO, SUITE 380, 21860 BURBANK BLVD., WOODLAND HILLS CA 91367